Astrana Health (ASTH) Net Income towards Common Stockholders (2010 - 2026)

Astrana Health (ASTH) has 17 years of Net Income towards Common Stockholders data on file, last reported at $13.1 million in Q1 2026.

• Quarterly Net Income towards Common Stockholders rose 111.08% year-over-year to $13.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.7 million (down 23.81% YoY) and the FY2025 annual result came in at $19.8 million, down 56.68% from the prior year.
• Net Income towards Common Stockholders climbed to $13.1 million in Q1 2026 per ASTH's latest filing, from $2.3 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $28.0 million in Q3 2023, with the low at -$12.5 million in Q4 2023.
• Average Net Income towards Common Stockholders over 5 years is $10.0 million, with a median of $11.4 million recorded in 2022.
• Year-over-year, Net Income towards Common Stockholders surged 557.01% in 2022 and sank 1319.93% in 2023.
• Astrana Health's Net Income towards Common Stockholders stood at -$883000.0 in 2022, then slumped by 1319.93% to -$12.5 million in 2023, then grew by 4.08% to -$12.0 million in 2024, then surged by 118.92% to $2.3 million in 2025, then surged by 477.19% to $13.1 million in 2026.
• Business Quant data shows ASTH's Net Income towards Common Stockholders at $13.1 million in Q1 2026, $2.3 million in Q4 2025, and $1.1 million in Q3 2025.